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Invasive gastric Candida infection in patient with co-morbidity 
can cause stenotic change if it is developed at anatomi-
cally narrowing portion, such as distal antrum, pylorus, or 
duodenal bulb. However, proper management of benign 
stenosis by diffuse gastric Candidasis is still under contro-
versy and palliative bypass surgery has several shortcomings 
because high risk operative group may be included in this 
case. Palliative placement of self-expandable metallic stent 
has been settled as a standard management of malignant 
gastric pyloric obstruction and it is expected to be applied in 
benign stenotic lesions due to its gradual dilation effect. We 
described a case of stenosis by diffuse gastric Candidasis at 
anastomosis of subtotal gastrectomy, which was managed 
by temporary placement of self-expandable metallic stent. 
(Gut Liver 2011;5:238-241)
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INTRODUCTION
Normally colonized Candida species in digestive tract may 
grow abnormally and cause plaques or ulcers at mucosa under 
various conditions (i.e., diabetes, administration of steroids, an-
tibiotics or anti-cancer drugs, malignancy, gastric resection).
1,2 
Most of Candida infection in the stomach is presented as ulcer-
ations or plaques, or both,
3-6 and may cause stenotic change if 
diffuse Candida infection is developed at anatomically narrow-
ing portion, such as distal antrum, pylorus, or duodenal bulb. 
We describe a case of pyloric stenosis due to diffuse gastric 
Candida infection, which was successfully managed by tempo-
rary insertion of self-expandable metallic stent (SEMS).
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CASE REPORT
A 69-year-old man with type 2 diabetes mellitus was referred 
to Division of Gastroenterology, Korea University Guro Hospital 
with anorexia, nausea, vomiting, and epigastric pain. He was di-
agnosed as diabetes 15 years ago and his blood sugar was con-
trolled by oral hypoglycemic agents. He had undergone subtotal 
gastrectomy with Billroth-I anastomosis due to advanced gastric 
cancer (Borrman type 3, T2N0M0) before one month from re-
ferral. He had suffered from drowsiness and purulent sputum, 
and was treated with intravenous antibiotics due to aspiration 
pneumonia during post-operative care. He did not receive any 
anti-acid agents, anti-H-2 receptors or oral proton pump in-
Fig. 1. Esophagogastroduodenoscopic findings at the time of diagno-
sis of invasive gastric Candidiasis. A diffuse mucosal defect covered 
with a greenish to yellow plaque is noted at the anastomosis site.
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hibitors (PPIs) at that time. His absolute neutrophil count was 
within normal limit and anti-human immunodeficiency virus 
(HIV) antibody was negative. An esophagogastroduodenoscopy 
showed a diffuse mucosal defect at remnant stomach body, 
which was covered with greenish to yellowish plaque and exu-
dates (Fig. 1).  Biopsies were performed at ulcerative lesions and 
its histologic findings demonstrated that there were many yeast 
forms of fungal organism with chronic active ulcer, which was 
compatible with gastric Candidiasis (Fig. 2). Oral fluconazole 
was administered for more than two weeks, however follow-up 
esophagogastroduodenoscopy could not show any improve-
ment of above mentioned lesion. Therefore, amphoterecin B was 
given intravenously for 10 days. His symptoms and endoscopic 
findings were improved and he was discharged after completion 
of intravenous amphoterecin B treatment.
However, his nausea and vomiting recurred after discharge, 
thus he underwent follow-up esophagogastroduodenoscopy. 
Ulcerative lesion was much improved comparing with previous 
findings, however stenotic change at pre-anastomosis site was 
developed and tip of the scope could not be passed through the 
narrowing portion (Fig. 3A). Gastroduodenography also indi-
cated partial narrowing near anastomosis site (Fig. 3B). There-
fore we inserted SEMS (Bonastent
⡴, covered; Standard Sci Tech, 
Seoul, Korea) through the anastomosis site at three months after 
referral (Fig. 4A). After the procedure, his symptom was nearly 
resolved and did not recur thereafter. On follow-up esophago-
gastroduodenoscopy which was performed at two months after 
procedure, the stent was migrated from the anastomosis site and 
expelled outside the gastrointestinal tract spontaneously. How-
ever, anastomosis site remained dilated and the tip of endoscope 
could be passed through well (Fig. 4B). 
Fig. 2. Histopathologic findings of a chronic active ulcer using Gro-
cott’s Methenamine Silver stain (×400). Yeast forms of fungal organ-
isms were compatible with invasive gastric Candidiasis.
Fig. 3. (A) An esophagogastroduode-
noscopic finding following treatment 
of gastric Candidiasis. The tip of the 
scope can not be passed through the 
stenotic portion at the anastomosis 
site. (B) A gastroduodenographic 
finding. Partial narrowing near the 
anastomosis site is detected.
Fig. 4. Esophagogastroduodenoscop-
ic findings. (A) A self-expandable 
metallic stent is inserted through the 
stenotic lesion of the anastomosis 
site. (B) A follow-up esophagogas-
troduodenoscopy is performed two 
months following the procedure, at 
which point a widened lumen at the 
anastomosis site was observed.240  Gut and Liver, Vol. 5, No. 2, June 2011
DISCUSSION 
There are many conditions which are known to contribute to 
the colonization of Candida in gastrointestinal tract, especially 
in the stomach.
7 Hypoacidity after treatment with H-2 receptor 
blockers or PPIs is associated with colonization of fungus at 
stomach, and impaired gastric emptying and stasis due to gas-
tric resection or gastroneuropathy may also cause colonization 
by Candida.
7 Other systemic disease, such as immune-deficiency 
status, especially HIV-infected patients, chronic alcoholism, ma-
lignancy or diabetes may predispose to invasive Candida infec-
tion in extraesophageal gastrointestinal tract.
4,8 In our case, the 
patient had diabetes and underwent subtotal gastrectomy and 
these factors would contribute to the development of invasive 
gastric Candidiasis. 
Endoscopically, gastric Candida infection may aggravate and 
present as diffuse superficial erosions to large ulcers.
9 How-
ever, there are limited reports about the endoscopic features of 
Candida-infected ulcers. A previous study reported that unclear 
border, dirty aspect, bezoar-like morphology (i.e., foreign body), 
larger diameter (>2.0 cm) and proximal lesion were the charac-
teristic endoscopic findings of Candida infected ulcers.
4 Another 
previous study suggested that majority of benign gastric ulcers 
associated with Candida infection were found more frequently 
in fundic area and were rare in antrum or pre-pylorus.
3 Radio-
logic features of Candida-associated gastric ulcers are also little 
known. Few cases showed radiologic findings resembled those 
of metastatic gastric cancers or pyloric stenosis.
10 It is obvious 
that endoscopists should be careful to distinguish Candida-
infected ulcers from gastric malignancy, especially advanced 
gastric cancer or recurrent lesions.
3
As we mentioned above, stenosis can be developed if dif-
fuse Candida infection occurs at pre-pylorus or anastomosis 
site of subtotal gastrectomy. If such lesions failed to resolve 
spontaneously, optimal management is controversial and clini-
cians may consider palliative surgery (i.e., gastroenterostomy). 
However, this approach is not available in case of high risk 
operative group, such as old age or immune-deficiency status. 
Pyloric stenosis due to benign causes has been treated with 
endoscopic balloon dilatation as an alternative to surgery, how-
ever, although its short-term clinical outcome is favorable, the 
long-term results are often disappointing, with 51% of patients 
requiring subsequent surgery, 33% experiencing recurrent 
obstructions, and there is an associated risk of bleeding or per-
foration.
11-13 In these cases, endoscopic procedure could be an 
alternative option. Temporary placement of SEMS may be ef-
fective for symptomatic improvement in benign pyloric stenosis 
as well as malignant stricture, although inserted stent could be 
migrated.
14-16 In our previous pilot study,
17 we observed 70% of 
sustained symptomatic improvement in patients with benign 
pyloric stricture due to recurrent gastric or duodenal ulcers in 
spite of high rate of stent migration (57%). Stent application 
in benign stenosis is expected to be beneficial due to more 
gradual and sustained dilatation in stenotic portion. In our case, 
symptomatic improvement was sustained and dilated lumen re-
mained for more than 2 months in spite of stent migration.
As far we know, there has been no reported case of stenotic 
change after fungal infection and its management with tempo-
rary stent insertion. We report a case of successful placement 
of SEMS in patient who had subtotal gastrectomy and stenotic 
change at anastomosis site after diffuse invasive gastric Candida 
infection and whose symptom was improved by the procedure. 
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